Great West Life Assurance CO Axogen, Inc. Transaction History

Great West Life Assurance CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$7.53 - $10.95 $59,494 - $86,515	7,901 Added 410.44%	9,826 $93,000
Q4 2022 Feb 10, 2023	BUY	$9.44 - $13.09 $18,172 - $25,198	1,925 New	1,925 $19,000
Q2 2022 Aug 09, 2022	SELL	$6.99 - $10.0 $15,930 - $22,790	-2,279 Closed	0 $0
Q3 2020 Nov 17, 2020	SELL	$10.62 - $13.12 $6.79 Million - $8.39 Million	-639,312 Reduced 99.64%	2,279 $26,000
Q3 2020 Nov 13, 2020	BUY	$10.62 - $13.12 $6.79 Million - $8.39 Million	639,312 Added 28052.3%	641,591 $7.46 Million
Q4 2019 Feb 11, 2020	BUY	$11.18 - $18.6 $25,479 - $42,389	2,279 New	2,279 $40,000
Q3 2019 Oct 25, 2019	SELL	$12.09 - $20.46 $51,926 - $87,875	-4,295 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$18.5 - $25.47 $14,374 - $19,790	777 Added 22.09%	4,295 $0
Q4 2017 Feb 09, 2018	BUY	$18.5 - $28.6 $65,083 - $100,614	3,518	3,518 $99,000

163

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $534M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.